New transplantable patient-derived xenograft (PDX) CRPC model with intrinsic ENZ-Resistance were used to access therapeutic efficacy of BIRC6 targeting antisense oligonucleotide (ASO-6w2). Molecular pathways associated with the inhibitory effect of ASO-6w2 vs control Scrb ASO were examined by gene e...
ORGANISM(S): Homo sapiens